Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.
References are not cited within this report. However, they are included in the supplement to this issue of the American Journal of Kidney Diseases, which contains reports regarding each topic that was considered by the panel. These recommendations are not intended to be guidelines or standards of care. Instead, they have been developed to provide the best available information and expert opinion in decision-making for the clinician. The recommendations should not be considered as prescribing an exclusive course of management.
Eknoyan
Garabed
G
Baylor College of Medicine, Houston, TX USA.
Latos
Derrick L
DL
Lindberg
Jill
J
D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D002331:Carnitine / Q000008:administration & dosage / Q000172:deficiency / Q000502:physiology / Q000627:therapeutic use*; D005221:Fatigue / Q000188:drug therapy / Q000209:etiology; D006706:Homeostasis; D006801:Humans; D007022:Hypotension / Q000188:drug therapy / Q000209:etiology; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000628:therapy; D006435:Renal Dialysis / Q000009:adverse effects*
D002331:Carnitine